Nanoscope Therapeutics Company
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
Industry:
Gene Therapy
Technology:
Cardiovascular Disorders
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Headquarters:
Bedford, Texas, United States
Founded Date:
2017